149 related articles for article (PubMed ID: 2339765)
1. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
Balabolkin MI; Gerasimov GA; Liubimov AV
Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
[TBL] [Abstract][Full Text] [Related]
2. [The value of functional tests in diagnosis of prolactinoma].
Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
[TBL] [Abstract][Full Text] [Related]
3. Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
Seki K; Uesato T; Kato K; Shima K
Endocrinol Jpn; 1984 Dec; 31(6):733-9. PubMed ID: 6532792
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
[TBL] [Abstract][Full Text] [Related]
5. The growth hormone, prolactin and TSH response to TRH and L-dopa in patients with hyperprolactinaemia and a normal-sized sella turcica may denote a pituitary adenoma.
Brismar K; Hulting AL; Werner S
J Intern Med; 1990 Nov; 228(5):435-42. PubMed ID: 2123920
[TBL] [Abstract][Full Text] [Related]
6. Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient.
Iglesias P; Díez JJ
Am J Med; 2011 Jun; 124(6):e3-4. PubMed ID: 21605718
[No Abstract] [Full Text] [Related]
7. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
[TBL] [Abstract][Full Text] [Related]
8. Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
Canales ES; Cano C; Ablanedo J; Zárate A
Horm Res; 1981; 15(4):213-7. PubMed ID: 6927819
[TBL] [Abstract][Full Text] [Related]
9. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
[TBL] [Abstract][Full Text] [Related]
10. [Prolactin and TSH response in functional tests in patients with primary hypothyroidism in a context of hyperprolactinemia].
Chernova TO; Kolesnikova GS; Mudretsova SV; Serpukhovitin SIu; Goncharov NP; Gereasimov GA
Probl Endokrinol (Mosk); 1994; 40(5):16-8. PubMed ID: 7899431
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
12. [The metoclopramide test in the differential diagnosis of various forms of galactorrhea-amenorrhea syndrome].
Oleĭnik VA; Luchitskiĭ EV; Valueva GV; Slavnov VN
Probl Endokrinol (Mosk); 1987; 33(4):34-6. PubMed ID: 3658947
[TBL] [Abstract][Full Text] [Related]
13. [Amineptine in the differential diagnosis of hyperprolactinemic states].
Casazza S; Contessi D; Gaslini MC; Maggi G; De Vincentiis S; Motta T; D'Alberton A
Minerva Ginecol; 1988 Jun; 40(6):357-62. PubMed ID: 3144680
[No Abstract] [Full Text] [Related]
14. Severe hyperprolactinemia associated with internal carotid artery aneurysm: differential diagnosis between prolactinoma and hypothalamic-pituitary disconnection.
Duarte FH; Machado MC; Lima JR; Salgado LR
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1189-93. PubMed ID: 19082309
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.
Tsigkaropoulou E; Peppa M; Zompola C; Rizos E; Xelioti I; Chatziioannou S; Filippopoulou A; Lykouras L
Gend Med; 2012 Feb; 9(1):56-60. PubMed ID: 22333523
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
17. [Pituitary tumor syndrome and hyperprolactinemia in peripheral hypothyroidism].
Abram M; Brue T; Morange I; Girard N; Guibout M; Jaquet P
Ann Endocrinol (Paris); 1992; 53(5-6):215-23. PubMed ID: 1340688
[TBL] [Abstract][Full Text] [Related]
18. [Dopaminergic regulation of the hypothalamo-hypophyseal system in patients with hypophyseal adenomas].
Balabolkin MI; Gerasimov GA; Snigireva RIa; Pisarskaia IV; Liubimov AV
Probl Endokrinol (Mosk); 1989; 35(5):3-6. PubMed ID: 2587520
[TBL] [Abstract][Full Text] [Related]
19. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Seki K; Kato K; Shima K
J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
[TBL] [Abstract][Full Text] [Related]
20. [Hypophyseal microprolactinoma as a cause of delayed puberty].
Heidemann PH; Stubbe P
Monatsschr Kinderheilkd; 1989 Nov; 137(11):743-6. PubMed ID: 2514354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
